A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO INVESTIGATE THE EFFICACY, SAFETY, AND TOLERABILITY OF LP352 IN THE TREATMENT OF SEIZURES IN CHILDREN AND ADULTS WITH DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES
- Registry ID
- LP352-301 (DEEP OCEAN)
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Phase
- PHASE3
- Study type
- INTERVENTIONAL
- Sponsor
- LONGBOARD PHARMACEUTICALS, INC.
- Start date
- 2026-05-01
- Last update
- 2025-03-21
Conditions
- EPILEPSY
- LENNOX-GASTAUT SYNDROME
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY
Related clinical trials
- A PHASE 3, OPEN-LABEL STUDY TO INVESTIGATE THE LONG-TERM SAFETY AND EFFICACY OF
LP352 IN THE TREATMENT OF SEIZURES IN CHILDREN AND ADULTS WITH DEVELOPMENTAL
AND EPILEPTIC ENCEPHALOPATHY
- FERUMOXYTOL ENHANCED HIPPOCAMPAL VASCULAR IMAGING IN EPILEPSY
- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 3 STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF XEN1101 AS ADJUNCTIVE THERAPY IN PRIMARY GENERALIZED TONIC-CLONIC SEIZURES
- AN OPEN-LABEL EXTENSION STUDY OF XEN496 IN PEDIATRIC SUBJECTS WITH KCNQ2 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY
- FLUNARIZINE FOR TREATMENT RESISTANT ABSENCE EPILEPSY
- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PADSEVONIL AS ADJUNCTIVE TREATMENT OF FOCAL-ONSET SEIZURES IN ADULT SUBJECTS WITH DRUG-RESISTANT EPILEPSY
View on source registry